Skip to main content
Year archive

3SBio Inc. — 2023 filings

All 80 regulatory filings released by 3SBio Inc. (1530) in 2023, sourced directly from the official regulator.

80 Filings
2023 Period
2023 filings (80)
Filing Released Lang
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Regulatory Filings
2023-12-01 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2023
Regulatory Filings
2023-12-01 English
VOLUNTARY ANNOUNCEMENT OF 3SBIO INC. -3SBIO INC.HAS ENTERED INTO LICENSING AGREEMENT WITH CSTONE PHARMACEUTICALS IN RESPECT OF ANTI-PD-1 MONOCLONAL ANTIBODY NOFAZINLIMAB
Regulatory Filings
2023-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Regulatory Filings
2023-11-01 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2023
Regulatory Filings
2023-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Regulatory Filings
2023-10-05 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2023
Regulatory Filings
2023-10-03 English
Notification Letter to Non-registered Holders and Request Form
Regulatory Filings
2023-09-28 English
Notification Letter to Registered Shareholders and Change Request Form
Regulatory Filings
2023-09-28 English
2023 INTERIM REPORT
Regulatory Filings
2023-09-28 English
Notification Letter and Request Form to Non-registered Shareholders - Notice of publication of 2023 Interim Report
Regulatory Filings
2023-09-28 English
Letter to Registered Shareholders - Notice of publication of 2023 Interim Report
Regulatory Filings
2023-09-28 English
2023 Interim Report
Regulatory Filings
2023-09-28 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
Regulatory Filings
2023-09-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2023
Regulatory Filings
2023-09-04 English
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
Regulatory Filings
2023-08-30 English
Next Day Disclosure Return
Regulatory Filings
2023-08-29 English
WITHDRAWAL OF LISTING OF ZERO COUPON CONVERTIBLE BONDS DUE 2025
Regulatory Filings
2023-08-29 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
Regulatory Filings
2023-08-24 English
DATE OF BOARD MEETING
Regulatory Filings
2023-08-18 English
NOTICE OF BOARD MEETING
Regulatory Filings
2023-08-11 English
PROFIT WARNING
Regulatory Filings
2023-08-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Regulatory Filings
2023-08-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2023
Regulatory Filings
2023-08-01 English
VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF CHIEF FINANCIAL OFFICER
Regulatory Filings
2023-07-28 English
Memorandum of Association and Bye-laws
Regulatory Filings
2023-07-27 English
EXERCISE OF CLEAN-UP CALL OPTION UNDER ZERO COUPON CONVERTIBLE BONDS DUE 2025
Regulatory Filings
2023-07-26 English
(1) FURTHER EXTENSION OF FACILITY AGREEMENT (2) COMPLETION OF REDEMPTION OF CONVERTIBLE BONDS PURSUANT TO EXERCISE OF PUT OPTION BY BONDHOLDERS
Regulatory Filings
2023-07-17 English
VOLUNTARY ANNOUNCEMENT - NARFURAPHINE HYDROCHLORIDE ORALLY DISINTEGRATING TABLETS CO-DEVELOPED BY 3SBIO INC. AND TORAY IN JAPAN APPROVED FOR LAUNCH IN THE MARKET
Regulatory Filings
2023-07-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Regulatory Filings
2023-07-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2023
Regulatory Filings
2023-07-03 English
Next Day Disclosure Return
Regulatory Filings
2023-06-30 English
(1) ADJUSTMENT TO CONVERSION PRICE OF THE CONVERTIBLE BONDS (2) REDEMPTION OF CONVERTIBLE BONDS PURSUANT TO EXERCISE OF PUT OPTION BY BONDHOLDERS
Regulatory Filings
2023-06-29 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 20 JUNE 2023
Regulatory Filings
2023-06-20 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 2 JUNE 2023
Regulatory Filings
2023-06-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
Regulatory Filings
2023-06-01 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2023
Regulatory Filings
2023-06-01 English
NOTIFICATION LETTER TO NON-REGISTERED HOLDERS AND REQUEST FORM
Regulatory Filings
2023-05-22 English
NOTIFICATION LETTER TO SHAREHOLDERS AND CHANGE REQUEST FORM
Regulatory Filings
2023-05-22 English
PROXY FORM FOR ANNUAL GENERAL MEETING TO BE HELD ON TUESDAY, 20 JUNE 2023 AT 10 A.M.
Regulatory Filings
2023-05-22 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2023-05-22 English
GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS, DECLARATION AND PAYMENT OF FINAL DIVIDEND OUT OF THE SHARE PREMIUM ACCOUNT OF THE COMPANY AND NOTICE OF ANNUAL GENERAL MEETIN
Regulatory Filings
2023-05-22 English
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2022
Regulatory Filings
2023-05-22 English
VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN THE TRIAL OF PHASE III CLINICAL STUDY OF 3SBIO'S RECOMBINANT HUMAN THROMBOPOIETIN (rhTPO) INJECTION (TPIAO) IN THE TREATMENT OF CHRONIC LIVER DISE
Regulatory Filings
2023-05-22 English
Notification Letter and Request Form to Non-Registered Shareholders - Notice of publication of Circular in relation to (1) proposed grant of general mandates to issue and repurchase shares, (2) propos
Regulatory Filings
2023-05-08 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2023-05-08 English
Letter to Registered Shareholders - Notice of publication of Circular in relation to (1) proposed grant of general mandates to issue and repurchase shares, (2) proposed re-election of retiring directo
Regulatory Filings
2023-05-08 English
FORM OF PROXY
Regulatory Filings
2023-05-08 English
(1) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, (2) PROPOSED RE-ELECTION OF RETIRING DIRECTORS, (3) PROPOSED CAPITAL REORGANISATION AND (4) NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2023-05-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
Regulatory Filings
2023-05-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2023
Regulatory Filings
2023-05-02 English
NOTIFICATION LETTER to Shareholders and Non-Registered Shareholders
Regulatory Filings
2023-04-28 English
Notification Letter to Non-registered Holders and Request Form
Regulatory Filings
2023-04-28 English
Notification Letter to Shareholders and Change Request Form
Regulatory Filings
2023-04-28 English
2022 Environmental, Social and Governance Report
Regulatory Filings
2023-04-28 English
2022 ANNUAL REPORT
Regulatory Filings
2023-04-28 English
Letter and Reply Form to New Registered Shareholders - Election of Means of Receipt and Language of Corporate Communications
Regulatory Filings
2023-04-27 English
Notification Letter and Request Form to Non-registered Shareholders - Notice of publication of 2022 Annual Report
Regulatory Filings
2023-04-27 English
Letter to Registered Shareholders - Notice of publication of 2022 Annual Report
Regulatory Filings
2023-04-27 English
2022 ANNUAL REPORT
Regulatory Filings
2023-04-27 English
PROPOSED CAPITAL REORGANISATION
Regulatory Filings
2023-04-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
Regulatory Filings
2023-04-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2023
Regulatory Filings
2023-04-03 English
FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2022
Regulatory Filings
2023-03-30 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Regulatory Filings
2023-03-30 English
APPOINTMENT OF EXECUTIVE DIRECTOR
Regulatory Filings
2023-03-30 English
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2022
Regulatory Filings
2023-03-21 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022
Regulatory Filings
2023-03-21 English
DATE OF BOARD MEETING
Regulatory Filings
2023-03-20 English
NOTICE OF BOARD MEETING
Regulatory Filings
2023-03-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
Regulatory Filings
2023-03-02 English
PROFIT WARNING
Regulatory Filings
2023-03-01 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2023
Regulatory Filings
2023-03-01 English
BUSINESS UPDATE - TERMINATION OF EXCLUSIVE LICENSE AGREEMENT WITH ASTRAZENECA IN RESPECT OF BYETTA AND BYDUREON
Regulatory Filings
2023-02-28 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
Regulatory Filings
2023-02-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2023
Regulatory Filings
2023-02-01 English
TERMS OF REFERENCE OF REMUNERATION COMMITTEE
Regulatory Filings
2023-01-31 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
Regulatory Filings
2023-01-04 English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE RESIGNATION OF NON-EXECUTIVE DIRECTOR
Regulatory Filings
2023-01-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
Regulatory Filings
2023-01-03 English